C. Damoci

290 Pharmacokinetics and tissue biodistribution of a doxorubicin-antibody conjugate in mice

G. Griffiths, D. Goldenberg, H. Hansen, 2004 .

A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth

K. Persaud, K. Paz, K. Credille, 2014, Cancer biology & therapy.

Intrinsic Resistance to Cixutumumab Is Conferred by Distinct Isoforms of the Insulin Receptor

P. Houghton, Malcolm A. Smith, D. Ludwig, 2015, Molecular Cancer Research.

Abolishing the prelamin A ZMPSTE24 cleavage site leads to progeroid phenotypes with near-normal longevity in mice

Eric D. Spear, Wei Wu, W. Hsu, 2021, bioRxiv.

Rationally repurposed nitroxoline inhibits preclinical models of Epstein–Barr virus-associated lymphoproliferation

J. Miranda, C. Damoci, M. Ibáñez de Garayo, 2021, The Journal of antibiotics.

Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody.

Zhen-ping Zhu, Haifan Zhang, D. Ludwig, 2009, Neoplasia.

An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody.

Zhen-ping Zhu, Haifan Zhang, D. Ludwig, 2007, Biochemical and biophysical research communications.